BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33580422)

  • 1. Richter Syndrome.
    Condoluci A; Rossi D
    Curr Oncol Rep; 2021 Feb; 23(3):26. PubMed ID: 33580422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Richter Syndrome: Diagnostic and Therapeutic Management].
    Croizier C; Guièze R
    Bull Cancer; 2021 May; 108(5):521-527. PubMed ID: 33896586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.
    Jamroziak K; Tadmor T; Robak T; Polliack A
    Leuk Lymphoma; 2015 Jul; 56(7):1949-58. PubMed ID: 25356923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome and prognostic factors of patients with Richter syndrome: real-world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC).
    Abrisqueta P; Delgado J; Alcoceba M; Oliveira AC; Loscertales J; Hernández-Rivas JA; Ferrà C; Cordoba R; Yáñez L; Medina A; Motlló C; Iacoboni G; Villacampa G; González M; Bosch F
    Br J Haematol; 2020 Sep; 190(6):854-863. PubMed ID: 32519351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology and treatment of Richter syndrome.
    Rossi D; Spina V; Gaidano G
    Blood; 2018 Jun; 131(25):2761-2772. PubMed ID: 29692342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Richter transformation of CLL.
    Jain N; Keating MJ
    Expert Rev Hematol; 2016 Aug; 9(8):793-801. PubMed ID: 27351634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Richter's Syndrome.
    Condoluci A; Rossi D
    Curr Treat Options Oncol; 2017 Nov; 18(12):75. PubMed ID: 29159711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
    Wąsik-Szczepanek E; Szymczyk A; Szczepanek D; Wszoła-Kleinrok J; Chocholska S; Pluta A; Hus M
    Adv Clin Exp Med; 2018 Dec; 27(12):1683-1689. PubMed ID: 30156387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How we treat Richter syndrome.
    Parikh SA; Kay NE; Shanafelt TD
    Blood; 2014 Mar; 123(11):1647-57. PubMed ID: 24421328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Richter Syndrome in Chronic Lymphocytic Leukemia.
    Vitale C; Ferrajoli A
    Curr Hematol Malig Rep; 2016 Feb; 11(1):43-51. PubMed ID: 26830086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated Chronic Lymphocytic Leukemia and Richter Transformation in the Era of Novel Agents.
    Levy Yurkovski I; Tadmor T
    Acta Haematol; 2024; 147(1):73-83. PubMed ID: 37666234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to therapy in Richter syndrome: a systematic review with meta-analysis of early clinical trials.
    Sousa-Pimenta M; Martins Â; Mariz JM; Berraondo P
    Front Immunol; 2023; 14():1295293. PubMed ID: 38077330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed tomography textural analysis for the differentiation of chronic lymphocytic leukemia and diffuse large B cell lymphoma of Richter syndrome.
    Reinert CP; Federmann B; Hofmann J; Bösmüller H; Wirths S; Fritz J; Horger M
    Eur Radiol; 2019 Dec; 29(12):6911-6921. PubMed ID: 31236702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax.
    Gángó A; Kiss R; Farkas P; Hanna E; Demeter J; Deák B; Lévai D; Kotmayer L; Alpár D; Matolcsy A; Bödör C; Mátrai Z; Timár B
    Pathology; 2022 Feb; 54(1):95-103. PubMed ID: 34332791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Richter syndrome: pathogenesis and management.
    Rossi D; Gaidano G
    Semin Oncol; 2016 Apr; 43(2):311-9. PubMed ID: 27040710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin lymphoma transformation of chronic lymphocytic leukemia-A real life data from the Polish Lymphoma Research Group.
    Drozd-Sokołowska J; Zaucha JM; Żółtak T; Jamroziak K; Grzybowska-Izydorczyk O; Witkowska M; Waszczuk-Gajda A; Kaźmierczak M; Szczepaniak A; Subocz E; Knopińska-Posłuszny W; Hołojda J; Kopińska A; Hus I; Rybka J; Wołowiec D; Kwiatkowski J; Hałaburda K; Smolewski P; Giebel S; Wiktor-Jędrzejczak W
    Hematol Oncol; 2019 Oct; 37(4):383-391. PubMed ID: 31026087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology and Treatment of Richter Transformation.
    Condoluci A; Rossi D
    Front Oncol; 2022; 12():829983. PubMed ID: 35392219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group.
    Tadmor T; Shvidel L; Bairey O; Goldschmidt N; Ruchlemer R; Fineman R; Rahimi-Levene N; Herishanu Y; Yuklea M; Arad A; Aviv A; Polliack A;
    Am J Hematol; 2014 Nov; 89(11):E218-22. PubMed ID: 25110869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin's variant of Richter transformation in chronic lymphocytic leukemia; a retrospective study from the Israeli CLL study group.
    Tadmor T; Shvidel L; Goldschmidt N; Ruchlemer R; Fineman R; Bairey O; Rahimi-Levene N; Herishanu Y; Yuklea M; Arad A; Aviv A; Polliack A
    Anticancer Res; 2014 Feb; 34(2):785-90. PubMed ID: 24511013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Richter syndrome: biology, incidence, and therapeutic strategies.
    Tsimberidou AM; Keating MJ
    Cancer; 2005 Jan; 103(2):216-28. PubMed ID: 15578683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.